The Current State of Pediatric Acute Respiratory Distress Syndrome

Kirsten E Orloff1, David A Turner1, Kyle J Rehder1

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Duke Children's Hospital, Durham, North Carolina.

Insights

Pediatric acute respiratory distress syndrome (PARDS) is a serious condition in children requiring intensive care. This review covers the latest definition, risk stratification, and evidence-based management strategies for PARDS.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pulmonology
  • Pediatric Respiratory Diseases

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) is a major cause of illness and death in children.
  • Children with PARDS frequently need intensive care and mechanical ventilation.
  • Current management strategies for PARDS lack extensive supporting data beyond lung protective ventilation.

Purpose of the Study:

  • To review the physiological underpinnings of PARDS.
  • To discuss the updated 2015 Pediatric Acute Lung Injury Consensus Conference (PALICC) definition and its impact on understanding PARDS epidemiology, heterogeneity, and risk stratification.
  • To summarize current evidence for standard and adjunctive therapies in PARDS management.

Main Methods:

  • Literature review of existing studies and guidelines on PARDS.
  • Analysis of the 2015 PALICC definition and its implications.
  • Synthesis of evidence for current standards of care and adjunctive treatments.

Main Results:

  • The 2015 PALICC definition has enhanced the understanding of PARDS epidemiology and heterogeneity.
  • Risk stratification has improved with the new definition.
  • Evidence for optimal management strategies, especially for varying disease severity, is still limited and requires further research.

Conclusions:

  • PARDS remains a critical condition in pediatric intensive care.
  • The updated definition aids in better classification and understanding of the disease.
  • Further research is essential to establish evidence-based optimal management protocols for pediatric patients with PARDS.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
907
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
479
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
877
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
821
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
528